Average Co-Inventor Count = 4.72
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (12 from 1,168 patents)
2. Smithkline Beecham Corporation (7 from 2,198 patents)
3. Glaxosmithkline LLC (6 from 356 patents)
4. Glaxosmithkline Intellectual Property (no.2) Limited (1 from 92 patents)
5. Glaxosmithkline Intellectual Property Limited (0 patent)
26 patents:
1. 9753034 - Process for the identification of a compound which inhibits the binding of the first bromodomain of each of human BRD-2, BRD-3, and BRD-4
2. 9670221 - Furopyridines as bromodomain inhibitors
3. 9663533 - Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors
4. 9360482 - Process for the identification of a compound which inhibits the binding of the second bromodomain of each of human BRD-2, BRD-3, and BRD-4
5. 8778939 - Compounds
6. 8575204 - Nicotinamide derivates useful as P38 inhibitors
7. 8354416 - 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
8. 8252818 - Nicotinamide derivatives useful as P38 inhibitors
9. 8207176 - Compounds
10. 7709506 - Nicotinamide derivatives useful as p38 inhibitors
11. 7678801 - Compounds
12. 7642276 - Fused heteroaryl derivatives for use as P38 kinase inhibitors
13. 7598251 - Aminopyrazine derivatives and compositions
14. 7572790 - Biphenyl carboxylic amide p38 kinase inhibitors
15. 7514456 - Nicotinamide derivatives useful as p38 inhibitors